165 related articles for article (PubMed ID: 10720035)
1. The contribution of testosterone to skeletal development and maintenance: lessons from the androgen insensitivity syndrome.
Marcus R; Leary D; Schneider DL; Shane E; Favus M; Quigley CA
J Clin Endocrinol Metab; 2000 Mar; 85(3):1032-7. PubMed ID: 10720035
[TBL] [Abstract][Full Text] [Related]
2. Height and bone mineral density in androgen insensitivity syndrome with mutations in the androgen receptor gene.
Danilovic DL; Correa PH; Costa EM; Melo KF; Mendonca BB; Arnhold IJ
Osteoporos Int; 2007 Mar; 18(3):369-74. PubMed ID: 17077943
[TBL] [Abstract][Full Text] [Related]
3. Changes in bone mineral density after orchidectomy and hormone replacement therapy in individuals with androgen insensitivity syndrome.
Mizunuma H; Soda M; Okano H; Kagami I; Miyamoto S; Ohsawa M; Ibuki Y
Hum Reprod; 1998 Oct; 13(1O):2816-8. PubMed ID: 9804237
[TBL] [Abstract][Full Text] [Related]
4. Bone mineral density in the complete androgen insensitivity and 5alpha-reductase-2 deficiency syndromes.
Sobel V; Schwartz B; Zhu YS; Cordero JJ; Imperato-McGinley J
J Clin Endocrinol Metab; 2006 Aug; 91(8):3017-23. PubMed ID: 16735493
[TBL] [Abstract][Full Text] [Related]
5. Low bone mass is an infrequent feature of the adult growth hormone deficiency syndrome in middle-age adults and the elderly.
Murray RD; Columb B; Adams JE; Shalet SM
J Clin Endocrinol Metab; 2004 Mar; 89(3):1124-30. PubMed ID: 15001597
[TBL] [Abstract][Full Text] [Related]
6. [Study of bone mineral density in complete androgen insensitivity syndrome patients].
Tian QJ; Dai ZQ; Yu W; Tian JP; Lang JH
Zhonghua Fu Chan Ke Za Zhi; 2005 Dec; 40(12):799-802. PubMed ID: 16412322
[TBL] [Abstract][Full Text] [Related]
7. Vertebral bone mass, size, and volumetric density in women with spinal fractures.
Duan Y; Parfitt Am; Seeman E
J Bone Miner Res; 1999 Oct; 14(10):1796-802. PubMed ID: 10491228
[TBL] [Abstract][Full Text] [Related]
8. Comparison of bone mineral density and body proportions between women with complete androgen insensitivity syndrome and women with gonadal dysgenesis.
Han TS; Goswami D; Trikudanathan S; Creighton SM; Conway GS
Eur J Endocrinol; 2008 Aug; 159(2):179-85. PubMed ID: 18463105
[TBL] [Abstract][Full Text] [Related]
9. Altered bone mineral density in patients with complete androgen insensitivity syndrome.
Bertelloni S; Baroncelli GI; Federico G; Cappa M; Lala R; Saggese G
Horm Res; 1998; 50(6):309-14. PubMed ID: 9973670
[TBL] [Abstract][Full Text] [Related]
10. Bone Mineral Density in Women Living with Complete Androgen Insensitivity Syndrome and Intact Testes or Removed Gonads.
Bertelloni S; Meriggiola MC; Dati E; Balsamo A; Baroncelli GI
Sex Dev; 2017; 11(4):182-189. PubMed ID: 28715798
[TBL] [Abstract][Full Text] [Related]
11. The bone mineral status of patients with Marfan syndrome.
Kohlmeier L; Gasner C; Bachrach LK; Marcus R
J Bone Miner Res; 1995 Oct; 10(10):1550-5. PubMed ID: 8686512
[TBL] [Abstract][Full Text] [Related]
12. Bone mineral density in sixty adult patients with Marfan syndrome.
Le Parc JM; Plantin P; Jondeau G; Goldschild M; Albert M; Boileau C
Osteoporos Int; 1999; 10(6):475-9. PubMed ID: 10663348
[TBL] [Abstract][Full Text] [Related]
13. Bone mineral density in complete androgen insensitivity syndrome and the timing of gonadectomy.
King TFJ; Wat WZM; Creighton SM; Conway GS
Clin Endocrinol (Oxf); 2017 Aug; 87(2):136-140. PubMed ID: 28493277
[TBL] [Abstract][Full Text] [Related]
14. Use of a Swedish T-score reference population for women causes a two-fold increase in the amount of postmenopausal Swedish patients that fulfill the WHO criteria for osteoporosis.
Ribom EL; Ljunggren O; Mallmin H
J Clin Densitom; 2008; 11(3):404-11. PubMed ID: 18280191
[TBL] [Abstract][Full Text] [Related]
15. Spinal and femoral bone mass accumulation during normal adolescence: comparison with female patients with sexual precocity and with hypogonadism.
Takahashi Y; Minamitani K; Kobayashi Y; Minagawa M; Yasuda T; Niimi H
J Clin Endocrinol Metab; 1996 Mar; 81(3):1248-53. PubMed ID: 8772607
[TBL] [Abstract][Full Text] [Related]
16. The effect of long-term growth hormone (GH) treatment on bone mineral density in children with GH deficiency. Role of GH in the attainment of peak bone mass.
Saggese G; Baroncelli GI; Bertelloni S; Barsanti S
J Clin Endocrinol Metab; 1996 Aug; 81(8):3077-83. PubMed ID: 8768878
[TBL] [Abstract][Full Text] [Related]
17. Osteopenia in eugonadal men with acquired immune deficiency syndrome wasting syndrome.
Fairfield WP; Finkelstein JS; Klibanski A; Grinspoon SK
J Clin Endocrinol Metab; 2001 May; 86(5):2020-6. PubMed ID: 11344201
[TBL] [Abstract][Full Text] [Related]
18. Combination treatment with estrogen and calcitriol in the prevention of age-related bone loss.
Gallagher JC; Fowler SE; Detter JR; Sherman SS
J Clin Endocrinol Metab; 2001 Aug; 86(8):3618-28. PubMed ID: 11502787
[TBL] [Abstract][Full Text] [Related]
19. Lumbar bone mineral density at final height and prevalence of fractures in treated children with GH deficiency.
Baroncelli GI; Bertelloni S; Sodini F; Saggese G
J Clin Endocrinol Metab; 2002 Aug; 87(8):3624-31. PubMed ID: 12161486
[TBL] [Abstract][Full Text] [Related]
20. Age, body mass index, and serum prostate-specific antigen correlate with bone loss in men with prostate cancer not receiving androgen deprivation therapy.
Conde FA; Sarna L; Oka RK; Vredevoe DL; Rettig MB; Aronson WJ
Urology; 2004 Aug; 64(2):335-40. PubMed ID: 15302490
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
